Edwards Lifesciences (EW) EBITDA (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly EBITDA of $477.6 million for Q1 2026, up 20.97% year-over-year from $394.8 million in Q1 2025, and up 216.08% quarter-over-quarter from $151.1 million in Q4 2025.
Edwards Lifesciences (EW) EBITDA (2009 - 2026) Analysis & Trends
Edwards Lifesciences' EBITDA history runs 18 years deep, the most recent figure standing at $477.6 million for Q1 2026.
- In Q1 2026, EBITDA rose 20.97% year-over-year to $477.6 million; the TTM figure through Mar 2026 stood at $1.3 billion (down 5.44% YoY), while the FY2025 annual figure was $1.3 billion, down 8.3% from the prior year.
- EBITDA for Q1 2026 stood at $477.6 million, up from $151.1 million in the prior quarter.
- The five-year high for EBITDA was $477.6 million in Q1 2026, with the low at $151.1 million in Q4 2025.
- The 5-year median for EBITDA is $365.9 million (2023), against an average of $352.0 million.
- The sharpest annual moves came in 2023 and 2025: EBITDA jumped 75.42% in 2023, then plunged 51.66% in 2025.
- Edwards Lifesciences' EBITDA stood at $197.7 million in 2022, then surged by 75.42% to $346.8 million in 2023, then dropped by 9.86% to $312.6 million in 2024, then slumped by 51.66% to $151.1 million in 2025, then soared by 216.08% to $477.6 million in 2026.
- Business Quant data shows EW's EBITDA at $477.6 million in Q1 2026, $151.1 million in Q4 2025, and $307.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 130.77 Bn | 127.30 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.82 Bn | 111.60 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 75.48 Bn | 74.94 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.90 Bn | 48.65 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.69 Bn | 32.75 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.47 Bn | 23.15 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.22 Bn | 22.74 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.44 Bn | 19.03 Bn | 1.54 Bn | 326.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 513.20 Mn |
| Mar 31, 2026 | 477.60 Mn |
| Dec 31, 2025 | 151.10 Mn |
| Sep 30, 2025 | 307.10 Mn |
| Jun 30, 2025 | 411.20 Mn |
| Mar 31, 2025 | 394.80 Mn |
| Dec 31, 2024 | 312.60 Mn |
| Sep 30, 2024 | 350.60 Mn |
| Jun 30, 2024 | 366.50 Mn |
| Mar 31, 2024 | 349.00 Mn |
| Dec 31, 2023 | 346.80 Mn |
| Sep 30, 2023 | 365.90 Mn |
| Jun 30, 2023 | 263.50 Mn |
| Mar 31, 2023 | 388.40 Mn |
| Dec 31, 2022 | 197.70 Mn |
| Sep 30, 2022 | 402.40 Mn |
| Jun 30, 2022 | 459.50 Mn |
| Mar 31, 2022 | 438.80 Mn |
| Dec 31, 2021 | 374.40 Mn |
| Sep 30, 2021 | 390.30 Mn |